FDA Law
FEBRUARY 16, 2023
sales of naloxone from a wholesale distributor to a harm reduction program) from certain requirements under the Drug Supply Chain Security Act. We previously blogged on FDA’s September 2022 guidance exempting and excluding specific naloxone transactions (e.g.,
BMJ
AUGUST 20, 2021
We used the first six years of the dataset to form a predictive model using Holt-Winters forecasting (a time series predictive method based on trends and seasonality), and then compared the observed data from November 2019 to November 2020 with the model to assess the impact of the COVID-19 pandemic on prescribing.
Expert insights. Personalized for you.
64 
Let's personalize your content